Tonix Pharmaceuticals Holding Corp.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.61-2.550.9114.76
Price/Sales ratio
943.29376.2044.1825.49
Earnings per Share (EPS)
$-22.08$-13.92$38.72$2.41

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
N/AN/AN/AN/AN/AN/A-1.22-1.41-0.12-0.05-0.17N/A
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.88N/AN/A
Price/Book Value ratio
N/AN/AN/AN/AN/AN/A0.720.590.060.060.10N/A
Price/Cash Flow ratio
N/AN/AN/AN/AN/AN/A-1.31-1.72-0.14-0.06-0.21N/A
Price/Free Cash Flow ratio
N/AN/AN/AN/AN/AN/A-1.11-1.17-0.09-0.06-0.14N/A
Price/Earnings Growth ratio
N/AN/AN/AN/AN/AN/AN/A0.020.000.000.00N/A
Dividend Yield
N/AN/AN/AN/AN/AN/A0.70%N/A46.79%N/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A38.96%N/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1523.94%N/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1501.77%N/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1501.77%N/AN/A
Effective Tax Rate
0.13%0.33%0.53%0.33%-0.89%0.82%0.14%0.08%-4.34%N/AN/A-0.89%
Return on Assets
-69.83%-102.20%-141.19%-78.95%-111.53%-213.57%-53.13%-38.30%-51.78%-75.52%-51.78%-111.53%
Return On Equity
-76.51%-119.35%-153.15%-85.81%-124.04%-330.16%-59.52%-42.19%-56.41%-110.55%-51.72%-124.04%
Return on Capital Employed
-76.48%-119.30%-153.45%-86.45%-111.23%-305.93%-57.16%-42.11%-54.01%-87.31%-38.24%-111.23%
Liquidity Ratios
Current Ratio
11.546.9712.8212.439.812.718.96N/AN/AN/A7.192.71
Quick Ratio
11.546.9712.8212.439.812.919.739.067.631.78N/A2.91
Cash ratio
11.292.888.9511.999.422.197.848.226.611.32N/A2.19
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A215.67N/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A-12.80-55.11-30.54-26.191.08KN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A1.30KN/AN/A
Days of Payables Outstanding
19.6223.108.1622.2119.4638.8733.2252.5126.27291.16N/A38.87
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A1.01KN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.050.08N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.080.08N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.050.00N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.070.00N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-96.19N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-11.44-129.01N/A
Company Equity Multiplier
1.091.161.081.081.111.541.121.101.081.461.081.54
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-13.13N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.001.001.001.001.171.461.491.071.491.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-11.44-129.01N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-43.40-226.97N/A
Dividend Payout Ratio
N/AN/AN/AN/A-11.12%-7.95%-0.86%N/A-5.69%N/AN/A-11.12%